MicroRNAs in Rheumatoid Arthritis

Panel A, MyD88-dependent TLR signaling pathway is regulated by miR-146a. Lipopolysaccharide (LPS) and peptidoglycan (PGN) activate immune cells through interaction with the TLR (TLR4, TLR 2/6) complex on the cell surface. This leads to the activation of the MyD88 dependent pathway, followed by the sequential recruitment of IRAK4, IRAK1, and TRAF6, and eventual activation of NF-κB. The active NF-κB is then exported to the nucleus where it activates the expression of pro-inflammatory cytokines, such as TNF-α and IL-1β. This pathway is normally used to control the growth and dissemination of the infectious agent and to activate the immune response as needed. However, if this mechanism is altered, the result is the pathological dysregulation leading to disease, as in the case of sepsis, multiorgan failure, autoimmune disease, or cancer. When NF-κB is activated, it also leads to the transcription of pri-miR146a and eventual maturation to miR-146a, which targets and down-regulates IRAK1 and TRAF6 through translational repression and degradation of mRNA. In the presence of LPS, miR-146a can increase up to 100 fold greater compared to untreated control monocytes. This negative feedback mechanism is induced by the high level of miR-146a, and it suppresses the expression of IRAK1 and TRAF6. In this way, the cell is able to enter a state of tolerance against further stimulation by LPS or many other TLR ligands.Panel B is a schematic of the relative expression of TNF-α, IRAK1/TRAF6, and miR-146a in the LPS-induced tolerance using the THP-1 cell model [,], in which tolerized cells quickly produce TNF-α, which continues for about 4–6 hours. When TNF-α production decreases, miR-146a starts to increase. Eighteen hours post-priming, a large difference is observed between TNF-α and miR-146a, as miR-146a acts negatively on IRAK1 and TRAF6 and the cells become tolerized. Tolerized cells do not respond to even higher dose of LPS challenge, due to the high levels of miR-146a, while untolerized cells respond to the second LPS challenge with higher production of TNF-α.
MicroRNAs in Rheumatoid Arthritis

Publication

MicroRNAs in Rheumatoid Arthritis. () Angela Ceribelli, et al. FEBS Lett. ;585(23):3667-3674. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates PGN PGN ncbigene_synonym SPG7 6687
Homo sapiens Primates LPS LPS ncbigene_synonym IRF6 3664
Homo sapiens Primates miR-146a MIR-146A ncbigene_synonym MIR146A 406938
Homo sapiens Primates TNF-a TNF-A ncbigene_synonym TNF 7124
Homo sapiens Primates TLR4 TLR4 ncbigene_symbol TLR4 7099
Homo sapiens Primates TLR2/6 TLR2 ncbigene_symbol TLR2 7097
Homo sapiens Primates TLR2/6 TLR6 ncbigene_symbol TLR6 10333
Homo sapiens Primates IRAK1 IRAK1 ncbigene_symbol IRAK1 3654
Homo sapiens Primates TRAF6 TRAF6 ncbigene_symbol TRAF6 7189
Homo sapiens Primates MyD88 MYD88 ncbigene_symbol MYD88 4615
Homo sapiens Primates IRAK4 IRAK4 ncbigene_symbol IRAK4 51135
Homo sapiens Primates NF-kB NF-KB ncbigene_synonym NFKB1 4790
Homo sapiens Primates IL-1B IL1B ncbigene_symbol IL1B 3553
Homo sapiens Primates (TNF-a,IL-1B,IL-6...) IL6 ncbigene_symbol IL6 3569
Danio rerio Vertebrates miR-146a MIR146A ncbigene_symbol mir146a 100628914
Danio rerio Vertebrates TNF-a TNF-A ncbigene_synonym tnfb 554167
Danio rerio Vertebrates TLR2/6 TLR2 ncbigene_symbol tlr2 403125
Danio rerio Vertebrates IRAK1 IRAK1 ncbigene_symbol irak1 569226
Danio rerio Vertebrates TRAF6 TRAF6 ncbigene_symbol traf6 554561
Danio rerio Vertebrates MyD88 MYD88 ncbigene_symbol myd88 403145
Danio rerio Vertebrates IRAK4 IRAK4 ncbigene_symbol irak4 393132
Danio rerio Vertebrates IL-1B IL1B ncbigene_symbol il1b 405770
Danio rerio Vertebrates (TNF-a,IL-1B,IL-6...) IL6 ncbigene_symbol il6 100885851
Danio rerio Vertebrates (TNF-a,IL-1B,IL-6...) TNFA ncbigene_symbol tnfa 405785

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID